Altimmune, Inc.

ALT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$95-$88-$85-$97
Dep. & Amort.$0$0$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$14$11$8$6
Change in WC$4-$8$14-$0
Other Non-Cash-$4$10-$1$13
Operating Cash Flow-$80-$76-$63-$78
Investing Activities
PP&E Inv.$0-$0-$0-$12
Net Acquisitions$0$0$0$0
Inv. Purchases-$116-$89-$73-$8
Inv. Sales/Matur.$87$102$0$107
Other Inv. Act.$0$0$0-$0
Investing Cash Flow-$28$14-$73$88
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$10$87$56$65
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$0$0
Financing Cash Flow$10$86$57$65
Forex Effect$0$0$0$0
Net Chg. in Cash-$98$24-$79$74
Supplemental Information
Beg. Cash$135$111$190$116
End Cash$37$135$111$190
Free Cash Flow-$80-$76-$63-$91
Altimmune, Inc. (ALT) Financial Statements & Key Stats | AlphaPilot